Marvin L. White

Insider Reports History

Entity
Individual
Location
2273 Research Blvd, Suite 400, Rockville, MD
Signature
/s/ SoYoung Kwon, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marvin L. White:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. Director Common Stock 68.4K $395K $5.78 May 23, 2024 Direct
Aptevo Therapeutics Inc. President and CEO, Director Common Stock 67.4K Mar 3, 2024 Direct
Emergent BioSolutions Inc. Director Stock Option (Right to Buy) 25.7K May 23, 2024 Direct
Aptevo Therapeutics Inc. President and CEO, Director Restricted Stock Unit 22.3K Jul 17, 2024 Direct
Aptevo Therapeutics Inc. President and CEO, Director Restricted Stock Unit 9.58K Mar 3, 2024 Direct

Insider Reports Filed by Marvin L. White

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APVO Aptevo Therapeutics Inc. Jul 17, 2024 1 $0 4 Jul 19, 2024 President and CEO, Director
EBS Emergent BioSolutions Inc. May 23, 2024 2 $0 4 May 28, 2024 Director
APVO Aptevo Therapeutics Inc. Mar 2, 2024 4 $0 4 Mar 5, 2024 President and CEO, Director
APVO Aptevo Therapeutics Inc. Jan 28, 2024 2 $0 4 Jan 30, 2024 President and CEO, Director
EBS Emergent BioSolutions Inc. May 25, 2023 1 $0 4 May 30, 2023 Director
APVO Aptevo Therapeutics Inc. Mar 3, 2023 4 $0 4 Mar 7, 2023 President and CEO, Director
APVO Aptevo Therapeutics Inc. Jan 29, 2023 2 $0 4 Jan 30, 2023 President and CEO, Director
APVO Aptevo Therapeutics Inc. Jun 7, 2022 1 $0 4 Jun 7, 2022 President and CEO, Director
EBS Emergent BioSolutions Inc. May 26, 2022 1 $0 4 May 31, 2022 Director
APVO Aptevo Therapeutics Inc. Mar 4, 2022 1 $0 4 Mar 4, 2022 President and CEO, Director
APVO Aptevo Therapeutics Inc. Jan 29, 2022 2 $0 4 Feb 1, 2022 President and CEO, Director
EBS Emergent BioSolutions Inc. May 20, 2021 1 $0 4 May 24, 2021 Director